Molina Healthcare, Inc. (MOH) - Form 8-K Summary
Business Context and Reporting Period
This filing is a Current Report on Form 8-K dated May 1, 2024, reporting the results of the Company's Annual Meeting of Stockholders held on that date. Molina Healthcare, Inc. is a Delaware corporation headquartered in Long Beach, California, with common stock trading on the New York Stock Exchange under the symbol MOH.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is limited to corporate governance voting results.
Material Changes and Voting Results
As of the record date (March 8, 2024), there were 58,583,802 shares outstanding. At the Annual Meeting, 51,263,601 shares (87.5%) were represented, constituting a quorum. The voting outcomes for the four proposals were as follows:
- Proposal 1 (Election of Directors): All nine nominees were elected. However, significant dissent was recorded for three directors:
- Steven J. Orlando: Received 4,611,955 votes against (approx. 9% of votes cast).
- Dale B. Wolf: Received 5,531,828 votes against (approx. 11% of votes cast).
- Ronna E. Romney: Received 7,548,829 votes against (approx. 15% of votes cast).
- Proposal 2 (Say-on-Pay): Approved. Received 46,266,687 votes for and 3,277,670 votes against.
- Proposal 3 (Ratification of Auditors): Approved. Ernst & Young LLP was ratified with 48,658,680 votes for and 2,568,533 votes against.
- Proposal 4 (Shareholder Proposal on Simple Majority Voting): Defeated. Received 4,541,115 votes for and 44,972,927 votes against.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of the voting results.
Investor Verification Checklist
- Verify the specific reasons for the elevated "against" votes for directors Steven J. Orlando, Dale B. Wolf, and Ronna E. Romney.
- Confirm the Company's response to the significant dissent regarding the Say-on-Pay proposal (approx. 7% against).
- Review the Company's stance on the defeated shareholder proposal regarding simple majority voting standards.
- Check subsequent filings for any changes to the Board composition or executive compensation policies resulting from this meeting.